Physicochemical and crystal structure analyses of the antidiabetic agent troglitazone

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 7, 2003, Pages 807-814

  Kobayashi, Katsuhiro ^a,b   Fukuhara, Hiroshi ^a   Hata, Tadashi ^a   Sekine, Akiko ^b   Uekusa, Hidehiro ^b   Ohashi, Yuji ^b  

^a DAIICHI SANKYO CO   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Antidiabetic agent; Crystal transformation; Dehydration; Hydrate; Mixed crystal; Single crystal structure X ray analysis

Indexed keywords

ACETONE; ACETONITRILE; ALCOHOL; ANTIDIABETIC AGENT; DICHLOROMETHANE; METHANOL; SOLVENT; TROGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CHROMAN DERIVATIVE;

AQUEOUS SOLUTION; ARTICLE; CRYSTAL; CRYSTAL STRUCTURE; CRYSTALLIZATION; DESICCATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STORAGE; DRUG STRUCTURE; HUMIDITY; PHYSICAL CHEMISTRY; STRUCTURE ANALYSIS; X RAY ANALYSIS; X RAY DIFFRACTION; CHEMICAL STRUCTURE; CHEMISTRY;

CHEMISTRY, PHYSICAL; CHROMANS; CRYSTALLIZATION; HYPOGLYCEMIC AGENTS; MOLECULAR STRUCTURE; THIAZOLIDINEDIONES;

EID: 1542785874     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.807     Document Type: Article

References (19)

1. Haleblian J. K., McCrone W., J. Pharm. Sci., 58, 911-929 (1969).
2. Haleblian J. K., J. Pharm. Sci., 64, 1269-1288 (1975).
3. Byrn S. R., "Solid-state Chemistry of Drugs", Academic, New York, 1982.
4. Borka L., Pharm. Acta Helv., 66, 16-22 (1991).
5. Sugi K., Itaya N., Katsura T., Igi, M., Yamazaki S., Ishibashi T., Yamaoka T., Kawada Y., Tagami Y., Otsuki M., Ohshima T., Chem. Pharm. Bull., 48, 529-536 (2000).
6. Kimura K., Hirayama F., Uemura K., J. Pharm. Sci., 88, 385-391 (1999).
7. Schinzer W. C., Bergren M. S., Aldrich D. S., Chao R. S., Dunn M. J., Jeganathan A., Madden L. M., J. Pharm. Sci., 86, 1426-1431 (1997).
8. Zhang G. G. Z., Gu C., Zell M. T., Burkhardt R. T., Munson E. J., Grant D. J. W., J. Pharm. Sci., 91, 1089-1100 (2002).
9. Crowley K. J., Zografi G., J. Pharm. Sci., 91, 492-507 (2002).
10. Vippagunta S. R., Brittain H. G., Grant D. J. W., Adv. Drug Del. Rev., 48, 3-26 (2001).
11. Yoshioka T., Fujita T., Kanai T., Aizawa Y., Kurumada T., Hasegawa K., Horikoshi H., J. Med. Chem., 32, 421-428 (1989).
12. Fujiwara T., Yoshioka S., Yoshioka T., Ushiyama I., Horikoshi H., Diabetes, 37, 1549-1558 (1988).
13. Suzuki N., Kasahara K., Hasegawa H., Kawasaki T., Int. J. Pharmaceut., 248, 71-80 (2002).
14. Kobayashi K., Fukuhara H., Yoshioka T., Hata T., Anal. Sci., 17, 467-468 (2001).
15. Altomare A., Burla M. C., Camalli M., Cascarano G. L., Giacovazzo C., Guagliardi A., Moliterni A. G. G., Polidori G., Spagna R., J. Appl. Crystallogr., 32, 115-119 (1999).
16. Sheldrick G. M., SHELXL-97, University of Goettingen, Germany, 1997.
17. Altomare A., Cascarano G., Giacovazzo C., Guagliardi A., Burla M. C., Polidori G., Camalli M., J. Appl. Crystallogr., 27, 435 (1994).
18. Vyas K., Sivalakshmidevi A., Prabhakar C., Reddy G. O., Acta Crystallogr., C55, 411-413 (1999).
19. Kobayashi K., Fukuhara H., Yoshioka T., Hata T., Anal. Sci., 16, 443-444 (2000).